Simplex Trading
GPCR icon

Simplex Trading’s Structure Therapeutics GPCR Stock Holding History

Simplex Trading’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Buy
+7,871
New +$348K ﹤0.01% 3820
2026
Q1 		– Sell
-92,668
Closed -$6.34M – 9473
2025
Q4 		$6.45M Buy
92,668
+67,507
+268% +$2.76M ﹤0.01% 1118
2025
Q3 		$704K Buy
25,161
+2,067
+9% +$41.2K ﹤0.01% 3420
2025
Q2 		$478K Buy
23,094
+2,490
+12% +$54.8K ﹤0.01% 3555
2025
Q1 		$356K Buy
20,604
+3,258
+19% +$79.8K ﹤0.01% 3757
2024
Q4 		$470K Sell
17,346
-3,913
-18% -$139K ﹤0.01% 3610
2024
Q3 		$933K Sell
21,259
-16,078
-43% -$622K ﹤0.01% 2979
2024
Q2 		$1.47M Buy
37,337
+14,372
+63% +$590K ﹤0.01% 2511
2024
Q1 		$984K Buy
22,965
+10,643
+86% +$449K ﹤0.01% 3141
2023
Q4 		$502K Buy
+12,322
New +$706K ﹤0.01% 3699

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Simplex Trading's GPCR Position: Q2 2026 in Review

Simplex Trading opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 7,871 shares worth $422K. The stake represents ﹤0.01% of the portfolio and ranks #3820 among its holdings. This is a return to the name: Simplex Trading previously reported a position in GPCR as recently as Q4 2025.

Simplex Trading first reported a position in GPCR in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.45M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Simplex Trading held 7,871 shares of Structure Therapeutics worth $422K as of Q2 2026.
  • Structure Therapeutics was a new Simplex Trading position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3820 holding.
  • Simplex Trading first reported a position in Structure Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Simplex Trading's Structure Therapeutics position peaked at $6.45M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.